Programs

HomePrograms ▶ Partner Grants
Partner Grants

Important Notes

Applicants are strongly advised to read the instructions and eligibility criteria before starting an application.
Letters of Intent (LOI) are available on the Foundant Technologies Website.
Invitations to submit a full application will be sent in October 2020. You must be invited to submit a full application.


Anticipated Timeline

June 1, 2020 Letter of Intent Period Opens
August 25, 2020 Deadline for Letter of Intent due by 11:59 pm Eastern Time
October 2020 Invitation from Scientific Advisory Committee for Full Applications
December 1, 2020 Full Application Deadline due by 11:59 pm Eastern Time
January 2021 Grantee Notification
February 2021 Grant Start Date

 
Current Partner Grant Opportunities

Alpha-1 Foundation

ATS/Alpha-1 Foundation Research Grant
1 grant available
$40,000 per year for 2 years

Target Audience:
Investigators (junior or established) interested in research that is relevant to alpha-1 antitrypsin deficiency (Alpha-1)

The focus of this research grant is proposals that have a high likelihood to advance the understanding of Alpha-1. Applications are encouraged from faculty members at any stage of their academic career. Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility:
• Junior investigators (as defined here) or established investigators at any stage in their career
• Applicants must not be current awardees of the Alpha-1 Foundation Research Program 
• Must meet eligibility requirements for all grants found here

Co-funded by the ATS Research Program and the Alpha-1 Foundation. Please visit alpha1.org for more information about our partner.

American Lung Association
ATS/American Lung Association Research Grant
1 grant available
$50,000 per year for 2 years

Target Audience:
Investigators working at Oregon, Washington, or Idaho-based institutions interested in research relevant to lung disease, sleep, and critical care

The focus of this research grant is basic science and patient-oriented research investigating lung disease, sleep, and critical care. We encourage proposals that investigate the impact of wildfires on patient outcomes. Patient-oriented research is defined as research performed with human subjects (or on material of human origin such as tissues or other specimen). This area of research includes 1) disease mechanism; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies. Applicants may request up to $50,000/year for 2 years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) 
• Applicants must be based at Idaho, Oregon, or Washington institutions
• Must meet eligibility requirements for all grants found here
 
Fully funded by the American Lung Association. Please visit lung.org for more information about our partner.

 
chILD Foundation

ATS/chILD Foundation Research Grant
1 grant available
$40,000 per year for 2 years

Target Audience:
Investigators (junior or established) interested in research that is relevant to Children's Insterstitial and Diffuse Lung Diseases (chILD)

The focus of this research grant is to advance the understanding, diagnosis, or treatment of chILD rare diseases. Examples of chILD diseases include surfactant dysfunction disorders, disorders of lung growth or lung development, lymphocytic interstitial lung disease, follicular bronchitis, bronchiolitis obliterans, pulmonary alveolar hemorrhage, pulmonary fibrosis, lung disease associated with immune dysregulation, neuroendocrine cell hyperplasia of infancy, pulmonary interstitial glycogenosis, surfactant dysfunction disorders, pulmonary alveolar proteinosis, and other chILD diseases. Relevant research could include investigations into underlying genetics, cell biology, and molecular pathways, or new diagnostic techniques, or evaluation of existing or novel therapies. 

Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) or established investigators at any stage in their career
• Must meet eligibility requirements for all grants found here 
 
Co-funded by the ATS Research Program and chILD Foundation. Please visit child-foundation.org for more information about our partner.

  

gsk-shield-logo.jpg

ATS/GSK Research Grant in Obstructive Lung Disease
1 grant available
$50,000 per year for 2 years

Target Audience:
Investigators interested in research that is relevant to obstructive lung disease

The focus of this research grant is proposals that advance understanding of obstructive lung disease.  
Applicants may request up to $50,000 per year for 2 years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility: 
• Junior investigators (as defined here) 
• Must meet eligibility requirements for all grants found here

Fully funded by GlaxoSmithKline. Please visit gsk.com for more information about our partner.
  

par-logo.jpg

ATS/ATS Public Advisory Roundtable (PAR) Research Grant
1 grant available
$40,000 for 1 year
Target Audience:
Investigators interested in lung disease research that is relevant to all PAR member organizations

The focus of this research grant is to fund research that is relevant to all disease areas represented by the ATS PAR member organizations. Applications should address translational research, implementation science, research in oxygen, or any research that is relevant to all PAR member organizations and is not specific to one organization or one disease state. Applicants may request up to $40,000 for one year for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here

Co-funded by the ATS Research Program and the ATS Public Advisory Roundtable (PAR). Please visit thoracic.org/patients/par/ for more information about our partner.


Review Process

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Advisory Committee (SAC) will review the applications in July 2020. The membership of the SAC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.


ATS Policy on Additional Grant Funding

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SAC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS Foundation research grant and the other grant. Budgetary overlap is not allowed.


If your question is not answered in the FAQ, contact the Research Program at researchprogram@thoracic.org.

 

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.